Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Role of Kv7 channels in responses of the pulmonary circulation to hypoxia

V. Sedivy, S. Joshi, Y. Ghaly, R. Mizera, M. Zaloudikova, S. Brennan, J. Novotna, J. Herget, AM. Gurney,

. 2015 ; 308 (1) : L48-57. (Lung cellular and molecular physiology)

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014014

Grantová podpora
NT13358 MZ0 CEP - Centrální evidence projektů

Hypoxic pulmonary vasoconstriction (HPV) is a beneficial mechanism that diverts blood from hypoxic alveoli to better ventilated areas of the lung, but breathing hypoxic air causes the pulmonary circulation to become hypertensive. Responses to airway hypoxia are associated with depolarization of smooth muscle cells in the pulmonary arteries and reduced activity of K(+) channels. As Kv7 channels have been proposed to play a key role in regulating the smooth muscle membrane potential, we investigated their involvement in the development of HPV and hypoxia-induced pulmonary hypertension. Vascular effects of the selective Kv7 blocker, linopirdine, and Kv7 activator, flupirtine, were investigated in isolated, saline-perfused lungs from rats maintained for 3-5 days in an isobaric hypoxic chamber (FiO2 = 0.1) or room air. Linopirdine increased vascular resistance in lungs from normoxic, but not hypoxic rats. This effect was associated with reduced mRNA expression of the Kv7.4 channel α-subunit in hypoxic arteries, whereas Kv7.1 and Kv7.5 were unaffected. Flupirtine had no effect in normoxic lungs but reduced vascular resistance in hypoxic lungs. Moreover, oral dosing with flupirtine (30 mg/kg/day) prevented short-term in vivo hypoxia from increasing pulmonary vascular resistance and sensitizing the arteries to acute hypoxia. These findings suggest a protective role for Kv7.4 channels in the pulmonary circulation, limiting its reactivity to pressor agents and preventing hypoxia-induced pulmonary hypertension. They also provide further support for the therapeutic potential of Kv7 activators in pulmonary vascular disease.

000      
00000naa a2200000 a 4500
001      
bmc15014014
003      
CZ-PrNML
005      
20190920125426.0
007      
ta
008      
150420s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1152/ajplung.00362.2013 $2 doi
035    __
$a (PubMed)25361569
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Šedivý, Vojtěch $u Department of Physiology, Charles University - Second Faculty of Medicine, Prague, Czech Republic; Department of Paediatrics, Charles University - Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; and vojtech.sedivy@seznam.cz. $7 xx0216304
245    10
$a Role of Kv7 channels in responses of the pulmonary circulation to hypoxia / $c V. Sedivy, S. Joshi, Y. Ghaly, R. Mizera, M. Zaloudikova, S. Brennan, J. Novotna, J. Herget, AM. Gurney,
520    9_
$a Hypoxic pulmonary vasoconstriction (HPV) is a beneficial mechanism that diverts blood from hypoxic alveoli to better ventilated areas of the lung, but breathing hypoxic air causes the pulmonary circulation to become hypertensive. Responses to airway hypoxia are associated with depolarization of smooth muscle cells in the pulmonary arteries and reduced activity of K(+) channels. As Kv7 channels have been proposed to play a key role in regulating the smooth muscle membrane potential, we investigated their involvement in the development of HPV and hypoxia-induced pulmonary hypertension. Vascular effects of the selective Kv7 blocker, linopirdine, and Kv7 activator, flupirtine, were investigated in isolated, saline-perfused lungs from rats maintained for 3-5 days in an isobaric hypoxic chamber (FiO2 = 0.1) or room air. Linopirdine increased vascular resistance in lungs from normoxic, but not hypoxic rats. This effect was associated with reduced mRNA expression of the Kv7.4 channel α-subunit in hypoxic arteries, whereas Kv7.1 and Kv7.5 were unaffected. Flupirtine had no effect in normoxic lungs but reduced vascular resistance in hypoxic lungs. Moreover, oral dosing with flupirtine (30 mg/kg/day) prevented short-term in vivo hypoxia from increasing pulmonary vascular resistance and sensitizing the arteries to acute hypoxia. These findings suggest a protective role for Kv7.4 channels in the pulmonary circulation, limiting its reactivity to pressor agents and preventing hypoxia-induced pulmonary hypertension. They also provide further support for the therapeutic potential of Kv7 activators in pulmonary vascular disease.
650    _2
$a aminopyridiny $x farmakologie $7 D000631
650    _2
$a analgetika $x farmakologie $7 D000700
650    _2
$a zvířata $7 D000818
650    12
$a hypoxie $x metabolismus $x patologie $x patofyziologie $7 D000860
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a plicní hypertenze $x metabolismus $x patologie $x patofyziologie $7 D006976
650    _2
$a indoly $x farmakologie $7 D007211
650    _2
$a draslíkové kanály KCNQ $x antagonisté a inhibitory $x metabolismus $7 D051656
650    12
$a plíce $x krevní zásobení $x metabolismus $x patologie $x patofyziologie $7 D008168
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové potenciály $x účinky léků $7 D008564
650    _2
$a hladké svalstvo $x metabolismus $x patologie $x patofyziologie $7 D009130
650    _2
$a blokátory draslíkových kanálů $x farmakologie $7 D026902
650    _2
$a arteria pulmonalis $x metabolismus $x patologie $x patofyziologie $7 D011651
650    12
$a plicní oběh $7 D011652
650    _2
$a pyridiny $x farmakologie $7 D011725
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a cévní rezistence $x účinky léků $7 D014655
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Joshi, Shreena $u Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom;
700    1_
$a Ghaly, Youssef $u Department of Physiology, Charles University - Second Faculty of Medicine, Prague, Czech Republic;
700    1_
$a Mizera, Roman $u Department of Physiology, Charles University - Second Faculty of Medicine, Prague, Czech Republic; $7 xx0227543
700    1_
$a Žaloudíková, Marie, $u Department of Pathophysiology, Charles University - Second Faculty of Medicine, Prague, Czech Republic; $d 1971- $7 xx0206604
700    1_
$a Brennan, Sean $u Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom;
700    1_
$a Novotna, Jana $u Department of Biochemistry, Charles University - Second Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Herget, Jan, $u Department of Physiology, Charles University - Second Faculty of Medicine, Prague, Czech Republic; $d 1945-2019 $7 nlk19990073223
700    1_
$a Gurney, Alison M $u Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom;
773    0_
$w MED00000288 $t American journal of physiology. Lung cellular and molecular physiology. Lung cellular and molecular physiology $x 1522-1504 $g Roč. 308, č. 1 (2015), s. L48-57
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25361569 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20190920125819 $b ABA008
999    __
$a ok $b bmc $g 1071595 $s 896892
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 308 $c 1 $d L48-57 $i 1522-1504 $m American journal of physiology. Lung cellular and molecular physiology $n Am J Physiol Lung Cell Mol Physiol $x MED00000288 $o Lung cellular and molecular physiology
GRA    __
$a NT13358 $p MZ0
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Možnosti archivace